A preparation method of rgd-m13 phage/polylysine/oxidized regenerated cellulose composite hemostatic material
A RGD-M13, regenerated cellulose technology, applied in pharmaceutical formulations, medical science, bandages, etc., can solve the problems of small increase in hemostasis time, reduced mechanical strength and bioabsorbability of oxidized regenerated cellulose, etc., and achieve hemostasis time. reduced effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
specific Embodiment approach 1
[0020] Embodiment 1: This embodiment is a preparation method of RGD-M13 bacteriophage / polylysine / oxidized regenerated cellulose composite hemostatic material, which is completed according to the following steps:
[0021] 1. Self-assembly of polylysine: immerse the oxidized regenerated cellulose into an aqueous solution of polylysine with a mass fraction of 0.01% to 0.1%, then let it stand at room temperature for 10min to 30min, and then oxidize the regenerated cellulose from The mass fraction is 0.01%~0.1% polylysine aqueous solution is taken out, obtains the oxidized regenerated cellulose modified by polylysine; Use deionized water to wash the oxidized regenerated cellulose modified by polylysine 10 times~ 20 times, and then vacuum freeze-drying at a temperature of -70°C to -40°C for 40h to 80h to obtain dry polylysine-modified oxidized regenerated cellulose;
[0022] The mass fraction of carboxyl groups in the oxidized regenerated cellulose described in step 1 is 16% to 24%;...
specific Embodiment approach 2
[0033] Embodiment 2: The difference between this embodiment and Embodiment 1 is that the molecular weight of polylysine in the polylysine aqueous solution with a mass fraction of 0.01% to 0.1% in step 1 is 150,000 to 300,000. Other steps are the same as in the first embodiment.
specific Embodiment approach 3
[0034] Embodiment 3: The difference between this embodiment and Embodiment 1 or 2 is that the oxidized regenerated cellulose in step 1 exists in the form of short filaments, filaments or fabrics. Other steps are the same as those in Embodiment 1 or 2.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com